stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / ASTH / Revenue

Astrana Health, Inc. Revenue 2011–2025

Astrana Health, Inc. (ASTH) annual revenue by fiscal year, computed from SEC filings. Compound growth +61.4%/yr over 14 years.

Fiscal yearRevenueChange (YoY)
FY 2025$3.18B+56.4%
FY 2024$2.03B+46.7%
FY 2023$1.39B+21.2%
FY 2022$1.14B+47.8%
FY 2021$773.91M+12.6%
FY 2020$687.18M+22.6%
FY 2019$560.62M+7.8%
FY 2018$519.91M+45.9%
FY 2017$356.36M+520.5%
FY 2017$57.43M-81.2%
FY 2016$305.93M+594.5%
FY 2016$44.05M+33.5%
FY 2015$32.99M+214.7%
FY 2014$10.48M+34.8%
FY 2013$7.78M+52.2%
FY 2012$5.11M+31.2%
FY 2011$3.90M

Source: Astrana Health, Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Astrana Health, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Astrana Health, Inc. — frequently asked questions

What is Astrana Health, Inc.'s revenue?

Astrana Health, Inc. (ASTH) reported revenue of $3.18B for fiscal year 2025, per its SEC filings.

How has Astrana Health, Inc.'s revenue changed over time?

Between fiscal 2011 and 2025, ASTH's revenue grew at roughly 61.4% per year (compound annual rate), from $3.90M to $3.18B.

Where does this data come from?

Figures are computed from Astrana Health, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More ASTH financial history

Full ASTH fundamentals page → · All 1,500+ companies →